The prevalence of Vitamin D deficiency is significantly higher in adults with overweight/obesity compared to those with normal body mass index (BMI). The "entrapment" of Vitamin D in adipose tissue due to impaired lipolytic stimulation and/or adipose tissue dysfunction has been proposed as the driving mechanism. Exercise training has been proposed as a promising strategy to increase mobilization of Vitamin D from adipose tissue, given its well described role in stimulating lipolysis. Indeed, a recent study revealed that participation in moderate-intensity cardiovascular type exercise over winter can mitigate the decline in 25-hydroxyvitamin D \[25(OH)D\] in adults with overweight/obesity, independent of weight loss. The aim of this study is to investigate the impact of hybrid-type high-intensity interval training over winter on vitamin D metabolism, in adults with overweight/obesity.
Thirty adults with overweight/obesity (both males and females) who will meet the inclusion criteria will be randomly assigned to either an Exercise group (n=15) or a Control group (n=15). The Exercise group will participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period, while receiving a balanced diet. The Control group will receive a balanced diet but will not participate in exercise training. Both groups will provide a resting blood sample and undergo assessment of their body composition (via bioelectrical impedance analysis), daily dietary intake (via dietary recalls) and physical activity level (via accelerometry) at baseline (prior to intervention), 6 weeks and 12 weeks.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
30
Receive a balanced diet and participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period
Receive a balanced diet but abstain from any type of exercise training
Department of Physical Education and Sport Science, University of Thessaly
Trikala, Karyes, Greece
RECRUITINGChange in 25-hydroxyvitamin D concentration
25-OH-VD will be quantitatively determined in serum
Time frame: At baseline, 6 weeks and 12 weeks
Change in plasma Vitamin D binding protein concentration
Vitamin D binding protein concentration will be determined in plasma
Time frame: At baseline, 6 weeks and 12 weeks
Change in calcium concentration
Calcium concentration will be determined in serum
Time frame: At baseline, 6 weeks and 12 weeks
Change in albumin concentration
Albumin concentration will be determined in serum
Time frame: At baseline, 6 weeks and 12 weeks
Change in aspartate aminotransferase (SGOT) concentration
SGOT concentration will be determined in serum on a Clinical Chemistry analyzer
Time frame: At baseline, 6 weeks and 12 weeks
Change in alanine aminotransferase (SGPT) concentration
SGPT concentration will be determined in serum on a Clinical Chemistry analyzer
Time frame: At baseline, 6 weeks and 12 weeks
Change in gamma-glutamyl transferase (γ-GT) concentration
γ-GT concentration will be determined in serum on a Clinical Chemistry analyzer
Time frame: At baseline, 6 weeks and 12 weeks
Change in reduced glutathione concentration
Reduced glutathione concentration will be determined in blood erythrocytes
Time frame: At baseline, 6 weeks and 12 weeks
Change in oxidized glutathione concentration
Oxidized glutathione concentration will be determined in blood erythrocytes
Time frame: At baseline, 6 weeks and 12 weeks
Change in dietary intake
Dietary intake habits will be assessed through dietary recalls
Time frame: At baseline, 6 weeks and 12 weeks
Change in physical activity level
Physical activity will be assessed via accelerometry
Time frame: At baseline, 6 weeks and 12 weeks
Change in body composition
Body composistion will be assessed via bioelectrical impedance analysis (BIA)
Time frame: At baseline, 6 weeks and 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.